257 related articles for article (PubMed ID: 22460182)
1. Associations among chronic kidney disease, high total p-cresylsulfate and major adverse cardiac events.
Wang CP; Lu LF; Yu TH; Hung WC; Chiu CA; Chung FM; Hsu CC; Lu YC; Lee YJ; Houng JY
J Nephrol; 2013; 26(1):111-8. PubMed ID: 22460182
[TBL] [Abstract][Full Text] [Related]
2. Associations among chronic kidney disease, high total p-cresylsulfate and left ventricular systolic dysfunction.
Lu LF; Tang WH; Hsu CC; Tsai IT; Hung WC; Yu TH; Wu CC; Chung FM; Lu YC; Lee YJ; Wang CP
Clin Chim Acta; 2016 Jun; 457():63-8. PubMed ID: 27036086
[TBL] [Abstract][Full Text] [Related]
3. Increased cystatin C levels as a risk factor of cardiovascular events in patients with preserved estimated glomerular filtration rate after elective percutaneous coronary intervention with drug-eluting stents.
Sai E; Shimada K; Miyauchi K; Masaki Y; Kojima T; Miyazaki T; Kurata T; Ogita M; Tsuboi S; Yoshihara T; Miyazaki T; Ohsaka A; Daida H
Heart Vessels; 2016 May; 31(5):694-701. PubMed ID: 25863806
[TBL] [Abstract][Full Text] [Related]
4. Increased Levels of Total p-Cresylsulfate Are Associated with Pruritus in Patients with Chronic Kidney Disease.
Wang CP; Lu YC; Tsai IT; Tang WH; Hsu CC; Hung WC; Yu TH; Chen SC; Chung FM; Lee YJ; Houng JY
Dermatology; 2016; 232(3):363-70. PubMed ID: 27161100
[TBL] [Abstract][Full Text] [Related]
5. Serum surfactant protein D is associated with the prognosis in patients with chronic kidney disease.
Xie F; Wang X; Ding Z; Fan P; Fan L; Chen Z; Ma G
J Cardiovasc Med (Hagerstown); 2013 Jun; 14(6):461-5. PubMed ID: 23314596
[TBL] [Abstract][Full Text] [Related]
6. Uraemic toxins and cardiovascular disease across the chronic kidney disease spectrum: an observational study.
Rossi M; Campbell K; Johnson D; Stanton T; Pascoe E; Hawley C; Dimeski G; McWhinney B; Ungerer J; Isbel N
Nutr Metab Cardiovasc Dis; 2014 Sep; 24(9):1035-42. PubMed ID: 24880738
[TBL] [Abstract][Full Text] [Related]
7. Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients.
Kanbay M; Yilmaz MI; Apetrii M; Saglam M; Yaman H; Unal HU; Gok M; Caglar K; Oguz Y; Yenicesu M; Cetinkaya H; Eyileten T; Acikel C; Vural A; Covic A
Am J Nephrol; 2012; 36(3):228-37. PubMed ID: 22948239
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular mortality in chronic kidney disease patients undergoing percutaneous coronary intervention is mainly related to impaired P2Y12 inhibition by clopidogrel.
Morel O; El Ghannudi S; Jesel L; Radulescu B; Meyer N; Wiesel ML; Caillard S; Campia U; Moulin B; Gachet C; Ohlmann P
J Am Coll Cardiol; 2011 Jan; 57(4):399-408. PubMed ID: 21251579
[TBL] [Abstract][Full Text] [Related]
9. Relationship between severity of renal impairment and 2-year outcomes after sirolimus-eluting stent implantation.
Ota T; Umeda H; Yokota S; Miyata S; Takamura A; Sugino S; Hayashi K; Ishiki R; Takeichi Y; Iwase M; Inagaki H; Murohara T
Am Heart J; 2009 Jul; 158(1):92-8. PubMed ID: 19540397
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of chronic kidney disease on 10-year clinical outcomes among patients with acute coronary syndrome.
Dohi T; Kasai T; Miyauchi K; Takasu K; Kajimoto K; Kubota N; Amano A; Daida H
J Cardiol; 2012 Dec; 60(6):438-42. PubMed ID: 23063662
[TBL] [Abstract][Full Text] [Related]
11. Chronic kidney disease and the risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents.
Miao Y; Yu-Jie Z; Zhi-Jian W; Dong-Mei S; Yu-Yang L; Ying-Xin Z; Fei G; Shi-Wei Y; De-An J
Catheter Cardiovasc Interv; 2012 Sep; 80(3):361-7. PubMed ID: 22419375
[TBL] [Abstract][Full Text] [Related]
12. Selecting a prognostic renal surrogate for patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
Lee YH; Hsu CY; Huang YH; Su CW; Lin HC; Lee RC; Chiou YY; Huo TI; Lee SD
J Gastroenterol Hepatol; 2012 Oct; 27(10):1581-8. PubMed ID: 22497632
[TBL] [Abstract][Full Text] [Related]
13. Serum total p-cresylsulfate level is associated with abnormal QTc interval in stable angina patients with early stage of renal failure.
Tang WH; Wang CP; Yu TH; Hung WC; Chung FM; Lu YC; Hsu CC; Lu LF; Huang LL; Lee YJ; Lai WT
Clin Chim Acta; 2014 Nov; 437():25-30. PubMed ID: 25011013
[TBL] [Abstract][Full Text] [Related]
14. The impact of chronic kidney disease as a predictor of major cardiac events in patients with no evidence of coronary artery disease.
Furuhashi T; Moroi M; Joki N; Hase H; Masai H; Kunimasa T; Nakazato R; Fukuda H; Sugi K
J Cardiol; 2010 May; 55(3):328-36. PubMed ID: 20350504
[TBL] [Abstract][Full Text] [Related]
15. Handgrip strength is an independent predictor of renal outcomes in patients with chronic kidney diseases.
Chang YT; Wu HL; Guo HR; Cheng YY; Tseng CC; Wang MC; Lin CY; Sung JM
Nephrol Dial Transplant; 2011 Nov; 26(11):3588-95. PubMed ID: 21444362
[TBL] [Abstract][Full Text] [Related]
16. p-Cresol and Cardiovascular Risk in Kidney Transplant Recipients.
Ligabue G; Damiano F; Cuoghi A; De Biasi S; Bellei E; Granito M; Aldo T; Cossarizza A; Cappelli G
Transplant Proc; 2015 Sep; 47(7):2121-5. PubMed ID: 26361658
[TBL] [Abstract][Full Text] [Related]
17. Nonculprit coronary plaque characteristics of chronic kidney disease.
Kato K; Yonetsu T; Jia H; Abtahian F; Vergallo R; Hu S; Tian J; Kim SJ; Lee H; McNulty I; Lee S; Uemura S; Jang Y; Park SJ; Mizuno K; Yu B; Jang IK
Circ Cardiovasc Imaging; 2013 May; 6(3):448-56. PubMed ID: 23536265
[TBL] [Abstract][Full Text] [Related]
18. Visceral obesity assessed by computed tomography predicts cardiovascular events in chronic kidney disease patients.
Kamimura MA; Carrero JJ; Canziani ME; Watanabe R; Lemos MM; Cuppari L
Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):891-7. PubMed ID: 22841184
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of total p-cresylsulphate are associated with angiographic coronary atherosclerosis severity in stable angina patients with early stage of renal failure.
Wang CP; Lu LF; Yu TH; Hung WC; Chiu CA; Chung FM; Yeh LR; Chen HJ; Lee YJ; Houng JY
Atherosclerosis; 2010 Aug; 211(2):579-83. PubMed ID: 20427046
[TBL] [Abstract][Full Text] [Related]
20. P-cresyl sulfate is a valuable predictor of clinical outcomes in pre-ESRD patients.
Lin CJ; Pan CF; Chuang CK; Sun FJ; Wang DJ; Chen HH; Liu HL; Wu CJ
Biomed Res Int; 2014; 2014():526932. PubMed ID: 24592393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
